Meta ad revenue slows after EU gives users a privacy choice
Europe's Less-Personalized Ads model, live since the start of the year, is now showing up in Meta's earnings - and it is a warning shot for every business built on targeted advertising.

Loading the Newsroom
Curating from trusted global sources…
147 briefings · “so”
Europe's Less-Personalized Ads model, live since the start of the year, is now showing up in Meta's earnings - and it is a warning shot for every business built on targeted advertising.
Guardian investigation ties US-made stun guns to abuse of Palestinian detainees, putting Axon's export practices in the crosshairs.
Former Blizzard president Mike Ybarra says Microsoft should skip a $1,200-$1,800 next-gen launch and keep PS5 Pro and Series X until prices normalize.
Bots are rolling off the Fremont line, but a year-long scale-up and unresolved hand design stand between Tesla and its 2027 delivery goal.
Tesla's safety reel shows Waymo and Avride cutting into its lane, a subtle jab ahead of earnings and the Dallas Cybercab launch.
A new Airbnb policy barring host-imposed chores has owners vowing to strike and plotting workarounds, while guests cheer. The fallout could reshape cleaning fees and listing supply.
The social media giant's ad engine and AI bet absorbed a massive teen-safety settlement and a new $25B privacy fine, keeping growth on track.
Data-center demand has locked up most of Samsung's supply, and analysts now expect another double-digit price surge for consumer RAM.
A $66M Sequoia-led round doubles Blacksmith's valuation in two months, proving code validation is the new bottleneck in AI software development.
The world's largest EV battery maker is being squeezed as automakers diversify suppliers and build in-house cells, and the 10% slide signals what that means for the EV supply chain.
A new University of Mississippi and Cornell review finds precision weed tools can replace chemicals and labor, yet adoption comes with serious financial and operational hurdles.
A 10,000-person study finds standard antidepressants often fail these patients, but melatonin and morning sunlight may hit the real root cause.